Abstract Details

Title Ozanimod (RPC1063) Reduces Plasma Levels of Neurofilament Light Chain (NfL) in Patients With Relapsing Multiple Sclerosis (RMS): Results From RADIANCE Part A, a Randomized, Placebo-Controlled, Phase 2 Study

Topic Multiple Sclerosis

Presentation(s) P3 - (-)

Poster/Presentation
Number 395

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Brett Skolnick, PhD (Drug & Device Development Solutions, LLC)	No disclosure on file
Paul Frohna, MD, PhD, PharmD (Bioniz Therapeutics, Inc)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��